Kimberly-Clark (KMB) stock faces risks from the $48.7B Kenvue acquisition, high debt, and weak growth. Learn why analysts ...

Add in the steady cash returns from dividend stocks, and you can further increase your potential total returns. With this in ...

KVUE's stock performance has suffered from legacy investor selling, management turnover, litigation risks, and a profit ...

Americans, egged on by non-stop TV ads from personal injury lawyers, have gone on a “suing spree” that costs the nation billions of dollars and millions of jobs, according to a leading advocate for ...

With consumer prices continuing to rise, many older adults are searching for simple ways to save on everyday essentials. Yet ...

WASHINGTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The American Tort Reform Foundation named eight Judicial Hellholes® today in its 2025-2026 report, citing fraud allegations, high-dollar, nuclear ...

Some big US companies want to shift domicile to Nevada and Texas in a move that is upending the world of business law ...

"I will not allow Big Pharma to operate above the law or put their greed ahead of Texans’ well-being," said Paxton.

A Texas judge has ordered Tylenol-maker Kenvue Inc. and its former parent Johnson & Johnson to register with the Texas Secretary of State or risk being barred from doing business in the state.

Tylenol-maker Kenvue Inc. must comply with a Texas law requiring out-of-state businesses to register with the state or risk ...

Tylenol-maker Kenvue Inc. must comply with a Texas law requiring out-of-state businesses to register with the state or risk being barred from conducting business in Texas, a judge ruled.